Table 3. Univariate and multivariate survival analysis.
Disease-free survival
|
Overall survival
|
|||||||
---|---|---|---|---|---|---|---|---|
Univariate analysisa
|
Multivariate analysisb
|
Univariate analysisa
|
Multivariate analysisb
|
|||||
P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | |
Tumour stagec | <0.001 | — | <0.001 | 2.2 (1.7–2.8) | <0.001 | — | <0.001 | 2.1 (1.6–2.8) |
Histological graded | <0.001 | — | 0.04 | 1.4 (1.02–2.0) | <0.001 | — | 0.002 | 1.8 (1.2–2.5) |
Histological subtypee | <0.001 | — | 0.1 | 1.7 (0.9–3.4) | 0.002 | — | 0.6 | 1.3 (0.6–2.8) |
Age | <0.001 | 1.1 (1.0–1.1) | 0.001 | 1.04 (1.02–1.1) | <0.001 | 1.1 (1.0–1.1) | <0.001 | 1.1 (1.03–1.1) |
Plasma fibrinogen levelsf | 0.002b | 1.4 (1.1–1.8) | 0.04 | 1.3 (1.01–1.6) | 0.001 | 1.4 (1.1–1.8) | 0.01 | 1.4 (1.1–1.2) |
Abbreviation: HR (95% CI)=hazard ratio (95% confidence interval).
Kaplan–Meier analysis.
Multivariate Cox regression model.
FIGO I vs FIGO II vs FIGO III and IV.
G1 vs G2 vs G3.
Endometrioid vs non-endometrioid histology.
Plasma fibrinogen levels per 100 units.